Back to STIFEL FINANCIAL CORP

BCRX
Showing 8 of 25 quarters

Position history for STIFEL FINANCIAL CORP's holdings in BIOCRYST PHARMACEUTICALS INC

STIFEL FINANCIAL CORP holds 1.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $17.4M as of 2026-Q1. The position was increased (+0.0% shares). BCRX represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$17.4M

Current Shares

1.8M

Total Value Change

+$6M

Total Shares Change

-18,468

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.8M
+0.0%
$17.4M0.0%$8.69
28
2025-Q4
Increased
1.8M
+0.1%
$14.2M0.0%$7.66
28
2025-Q3
Decreased
1.8M
-0.0%
$13.8M0.0%$7.55
0
2025-Q2
Decreased
1.8M
-0.8%
$16.3M0.0%$9.36
0
2025-Q1
Decreased
1.8M
-0.3%
$13.8M0.0%$7.86
0
2024-Q4
Decreased
1.8M
-0.0%
$13.9M0.0%$7.53
0
2024-Q3
Decreased
1.8M
-0.0%
$14M0.0%$7.62
0
2024-Q2
Decreased
1.8M
-0.0%
$11.4M0.0%$6.18
0

Other major holders of BCRX: BlackRock, Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used